List of banned substances in Major League Baseball

Last updated

Major League Baseball's drug policy prohibits players from using, possessing, selling, facilitating the sale of, distributing, or facilitating the distribution of any Drug of Abuse and/or Steroid. Any and all drugs or substances listed under Schedule II of the Controlled Substances Act are considered drugs of abuse covered by the Program. Players who require prescription medication can still use it with a "Therapeutic Use Exemption" granted by MLB. [1]

Contents

In December 2019, MLB removed cannabinoids and added cocaine and opiates to its list of Drugs of Abuse. [2] However, players were told that they could still be suspended for possessing or selling cannabis, or driving under the influence of cannabis. [3]

List of banned substances (not exhaustive) [4] [5]

Drugs of abuse

  1. Synthetic cannabinoids
  2. Cocaine
  3. LSD
  4. Opiates (e.g., fentanyl, oxycodone, heroin, codeine, and morphine)
  5. Amphetamines (e.g., MDMA (Ecstasy), MDA, Meth)
  6. "Bath salts" (e.g., cathinone, synthetic cathinone, MDPV)
  7. GHB
  8. Phencyclidine (PCP)

Performance enhancing substances (steroids, growth factors, hormone modulators, masking agents)

  1. Androstanediol
  2. Androstanedione
  3. Androstatrienedione (ATD)
  4. Androstanolone
  5. Androstenediol
  6. Androstenedione
  7. Androst-2-en-17-one (2-androstenone, delta-2)
  8. Androsterone
  9. Bolandiol
  10. Bolasterone
  11. Boldenone
  12. Boldione
  13. Calusterone
  14. Clenbuterol
  15. Clostebol (chlortestosterone)
  16. Danazol
  17. Dehydrochloromethyltestosterone (DHCMT, turinabol)
  18. Dehydroepiandrosterone (DHEA)
  19. Desoxy-methyltestosterone (DMT, madol)
  20. Dihydrotestosterone
  21. Drostanolone
  22. Epiandrosterone
  23. Epi-dihydrotestosterone
  24. Epitestosterone
  25. Ethylestrenol
  26. Fluoxymesterone
  27. Formebolone
  28. Furazabol
  29. Gestrinone
  30. Halodrol
  31. 4-Hydroxytestosterone
  32. 7-Keto-DHEA
  33. Mestanolone
  34. Mesterolone
  35. Methandienone
  36. Methandriol
  37. Methasterone (superdrol)
  38. Methenolone
  39. Methylclostebol
  40. Methyldienolone
  41. Methylnortestosterone
  42. Methylstenbolone (ultradrol, m-sten)
  43. Methyltestosterone
  44. Methyltrienolone (metribolone)
  45. Mibolerone
  46. Nandrolone
  47. Norbolethone
  48. Norandrostenediol
  49. Norandrostenedione
  50. Norandrosterone
  51. Norbolethone (genabol)
  52. Norclostebol
  53. Norethandrolone
  54. Noretiocholanolone
  55. Oxabolone
  56. Oxandrolone
  57. Oxymesterone
  58. Oxymetholone
  59. Prasterone (DHEA)
  60. Promagnon
  61. Prostanozol
  62. Quinbolone
  63. Selective androgen receptor modulators (SARMs)
  64. Stanozolol
  65. Stenbolone
  66. Testosterone
  67. Tetrahydrogestrinone
  68. Tibolone
  69. Trenbolone
  70. Zeranol
  71. Zilpaterol
  72. Any salt, ester, or ether of a drug or substance listed above
  73. Human growth hormone (hGH), including all fragments (e.g., AOD9604, hGH fragment 176-191) and releasing factors including GHRHs (e.g., CJC-1295, sermorelin, tesamorelin), GHSs (e.g., ghrelin and its mimetics (e.g., anamorelin, ibutamoren (MK-0677), ipamorelin), and peptides (e.g., alexamorelin, GHRP-2 (pralmorelin), GHRP-6, hexarelin)
  74. Insulin-like growth factor (IGF-1), including all isomers of IGF-1 (mechano growth factors, thymosin beta-4)
  75. Gonadotrophins (hCG), including LH and hCG
  76. Corticotrophins, including releasing factors (corticorelin)
  77. Erythropoiesis stimulating agents, including (erythropoietin (EPO), darbepoetin (dEPO), hematide, methoxy polyethylene glycol-epoetin beta (CERA))
  78. Aromatase inhibitors, including anastrozole, androstatrienedione (ATD), androstenetrione (6-OXO), aminoglutethimide, arimistane, exemestane, formestane, letrozole, and testolactone
  79. Selective estrogen receptor modulators (SERMs), including bazedoxifene, ospemifene, raloxifen, tamoxifen, and toremifen
  80. Other Anti-estrogens, including clomiphene, cyclofenil, and fulvestrant
  81. Myostatin modifying agents, including myostatin inhibitors (e.g., follistatin)
  82. Metabolic modifying agents, including Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists (GW1516, GW501516, GW0742), AMP-activated protein kinase (AMPK) activators (AICAR, SR9009 (stenabolic)), meldonium (mildronate), trimetazidine
  83. HIF stabilizers, including roxadustat (FG-4592), molidustat (BAY 85-3934), FG-2216, BAY 87-2243.
  84. Masking agents, including diuretics, desmopressin, probenecid, plasma expanders (e.g., intravenous administration of albumin, dextran, hydroxyethyl starch and mannitol)
  85. Diuretics include acetazolamide, amiloride, bumetanide, canrenone, chlorthalidone, etacrynic acid, furosemide, indapamide, metolazone, spironolactone, thiazides (e.g., bendroflumethiazide, chlorothiazide, hydrochlorothiazide), triamterene, vaptans
  86. Gene doping, the use of nucleic acids that may alter genome sequences and/or gene expression, including gene editing, gene silencing, gene transfer, genetically modified cells

Stimulants

Prohibited Substances may be added to the list only by the unanimous vote of HPAC, provided that the addition by the federal government of a substance to Schedule I, II, or III will automatically result in that substance being added to the list.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Amphetamine</span> Central nervous system stimulant

Amphetamine is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Amphetamine was discovered as a chemical in 1887 by Lazăr Edeleanu, and then as a drug in the late 1920s. It exists as two enantiomers: levoamphetamine and dextroamphetamine. Amphetamine properly refers to a specific chemical, the racemic free base, which is equal parts of the two enantiomers in their pure amine forms. The term is frequently used informally to refer to any combination of the enantiomers, or to either of them alone. Historically, it has been used to treat nasal congestion and depression. Amphetamine is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. It is a prescription drug in many countries, and unauthorized possession and distribution of amphetamine are often tightly controlled due to the significant health risks associated with recreational use.

<span class="mw-page-title-main">Recreational drug use</span> Use of drugs with the primary intention to alter the state of consciousness

Recreational drug use is the use of one or more psychoactive drugs to induce an altered state of consciousness, either for pleasure or for some other casual purpose or pastime. When a psychoactive drug enters the user's body, it induces an intoxicating effect. Recreational drugs are commonly divided into three categories: depressants, stimulants, and hallucinogens.

<span class="mw-page-title-main">Narcotic</span> Chemical substance with psycho-active properties

The term narcotic originally referred medically to any psychoactive compound with numbing or paralyzing properties. In the United States, it has since become associated with opiates and opioids, commonly morphine and heroin, as well as derivatives of many of the compounds found within raw opium latex. The primary three are morphine, codeine, and thebaine.

<span class="mw-page-title-main">Psychopharmacology</span> Study of the effects of psychoactive drugs

Psychopharmacology is the scientific study of the effects drugs have on mood, sensation, thinking, behavior, judgment and evaluation, and memory. It is distinguished from neuropsychopharmacology, which emphasizes the correlation between drug-induced changes in the functioning of cells in the nervous system and changes in consciousness and behavior.

Stimulant psychosis is a mental disorder characterized by psychotic symptoms. It involves and typically occurs following an overdose or several day 'binge' on psychostimulants; however, one study reported occurrences at regularly prescribed doses in approximately 0.1% of individuals within the first several weeks after starting amphetamine or methylphenidate therapy. Methamphetamine psychosis, or long-term effects of stimulant use in the brain, depend upon genetics and may persist for some time.

Substance dependence, also known as drug dependence, is a biopsychological situation whereby an individual's functionality is dependent on the necessitated re-consumption of a psychoactive substance because of an adaptive state that has developed within the individual from psychoactive substance consumption that results in the experience of withdrawal and that necessitates the re-consumption of the drug. A drug addiction, a distinct concept from substance dependence, is defined as compulsive, out-of-control drug use, despite negative consequences. An addictive drug is a drug which is both rewarding and reinforcing. ΔFosB, a gene transcription factor, is now known to be a critical component and common factor in the development of virtually all forms of behavioral and drug addictions, but not dependence.

<span class="mw-page-title-main">Metandienone</span> Androgen and anabolic steroid

Metandienone, also known as methandienone or methandrostenolone and sold under the brand name Dianabol (D-Bol) among others, is an androgen and anabolic steroid (AAS) medication which is still quite often used because of its affordability and effectiveness for bulking cycles. It is also used non-medically for physique- and performance-enhancing purposes. It is often taken by mouth.

Major League Baseball's drug policy—the Joint Drug Prevention and Treatment Program—was established by agreement between the MLB Players Association and the Office of the Commissioner of Baseball. The goal was to deter and end the use of banned substances, including anabolic steroids and other illegal drugs, and to "provide for, in keeping with the overall purposes of the Program, an orderly, systematic, and cooperative resolution of any disputes that may arise concerning the existence, interpretation, or application" of the policy itself. The Joint Drug Prevention and Treatment Program was adopted in the Spring of 2006.

Lacing or cutting, in drug culture, refer to the act of using a substance to adulterate substances independent of the reason. The resulting substance is laced or cut.

Performance-enhancing substances, also known as performance-enhancing drugs (PEDs), are substances that are used to improve any form of activity performance in humans. A well-known example of cheating in sports involves doping in sport, where banned physical performance-enhancing drugs are used by athletes and bodybuilders. Athletic performance-enhancing substances are sometimes referred as ergogenic aids. Cognitive performance-enhancing drugs, commonly called nootropics, are sometimes used by students to improve academic performance. Performance-enhancing substances are also used by military personnel to enhance combat performance.

A drug with psychotomimetic actions mimics the symptoms of psychosis, including delusions and/or delirium, as opposed to only hallucinations. Psychotomimesis is the onset of psychotic symptoms following the administration of such a drug.

Psychological dependence is a cognitive disorder that involves emotional–motivational withdrawal symptoms – such as anxiety or anhedonia – upon cessation of prolonged drug abuse or certain repetitive behaviors. It develops through frequent exposure to certain psychoactive substances or behaviors, which leads to an individual requiring further exposure to avoid withdrawal symptoms, as a result of negative reinforcement. Neuronal counter-adaptation is believed to play a role in generating withdrawal symptoms, which could be mediated through changes in neurotransmitter activity or altered receptor expression. Environmental enrichment and physical activity can attenuate withdrawal symptoms.

<span class="mw-page-title-main">FOSB</span> Protein

Protein fosB, also known as FosB and G0/G1 switch regulatory protein 3 (G0S3), is a protein that in humans is encoded by the FBJ murine osteosarcoma viral oncogene homolog B (FOSB) gene.

<span class="mw-page-title-main">Conditioned place preference</span> Pavlovian conditioning

Conditioned place preference (CPP) is a form of Pavlovian conditioning used to measure the motivational effects of objects or experiences. This motivation comes from the pleasurable aspect of the experience, so that the brain can be reminded of the context that surrounded the "encounter". By measuring the amount of time an animal spends in an area that has been associated with a stimulus, researchers can infer the animal's liking for the stimulus. This paradigm can also be used to measure conditioned place aversion with an identical procedure involving aversive stimuli instead. Both procedures usually involve mice or rats as subjects. This procedure can be used to measure extinction and reinstatement of the conditioned stimulus. Certain drugs are used in this paradigm to measure their reinforcing properties. Two different methods are used to choose the compartments to be conditioned, and these are biased vs. unbiased. The biased method allows the animal to explore the apparatus, and the compartment they least prefer is the one that the drug is administered in and the one they most prefer is the one where the vehicle is injected. This method allows the animal to choose the compartment they get the drug and vehicle. In comparison, the unbiased method does not allow the animal to choose what compartment they get the drug and vehicle in. Instead, the researcher chooses the compartments.

<span class="mw-page-title-main">NCAA banned substances</span>

In the United States the National Collegiate Athletic Association (NCAA), has since the 1970s been patrolling the usage of illegal drugs and substances for student-athletes attending universities and colleges. In 1999, NCAA Drug Committee published a list containing substances banned for the usage to student-athletes. Year after year it is updated and given to those students participating in college sports. If any student is caught taking any of the substances, they are subjected to suspension or even banned from participating in NCAA sports and possibly attending the university.

<span class="mw-page-title-main">Addiction</span> Disorder resulting in compulsive behaviours

Addiction is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behaviour that produces natural reward, despite substantial harm and other negative consequences. Repetitive drug use often alters brain function in ways that perpetuate craving, and weakens self-control. This phenomenon – drugs reshaping brain function – has led to an understanding of addiction as a brain disorder with a complex variety of psychosocial as well as neurobiological factors that are implicated in addiction's development. Classic signs of addiction include compulsive engagement in rewarding stimuli, preoccupation with substances or behavior, and continued use despite negative consequences. Habits and patterns associated with addiction are typically characterized by immediate gratification, coupled with delayed deleterious effects.

Addiction vulnerability is an individual's risk of developing an addiction during their lifetime. There are a range of genetic and environmental risk factors for developing an addiction that vary across the population. Genetic and environmental risk factors each account for roughly half of an individual's risk for developing an addiction; the contribution from epigenetic risk factors to the total risk is unknown. Even in individuals with a relatively low genetic risk, exposure to sufficiently high doses of an addictive drug for a long period of time can result in an addiction. In other words, anyone can become an individual with a substance use disorder under particular circumstances. Research is working toward establishing a comprehensive picture of the neurobiology of addiction vulnerability, including all factors at work in propensity for addiction.

References

  1. "Are too many players getting therapeutic use exemptions?". ESPN.com. December 2, 2015.
  2. "Major League Baseball Drops Marijuana, Adds Opioids, Cocaine To 'Drugs Of Abuse' List". NPR. 2019-12-12. Retrieved 2022-07-18.
  3. "MLB: Players still subject to penalty for using pot". ESPN.com. February 29, 2020.
  4. MLB.com (July 1, 2015). "Prohibited Substance List" (PDF).
  5. "MAJOR LEAGUE BASEBALL'S MINOR LEAGUE DRUG PREVENTION AND TREATMENT PROGRAM" (PDF). Retrieved February 27, 2024.